Skip to main content
. 2022 Feb 1;11(2):e202100248. doi: 10.1002/open.202100248

Table 2.

Interaction scheme between PLpro inhibitor binding site amino acid residues and ligands (X depicts the presence of interaction)

Aminoacid residue

GRL 0617

Epicriptine

Methergoline

Ergometrine

ASP164

X

X

X

X

GLN269

X

X

X

GLU167

X

X

GLY163

X

LEU162

X

MET208

X

PRO247

X

X

PRO248

X

X

X

TYR264

X

X

X

X

TYR268

X

X

X

TYR273

X

X